Dietary Weight Loss in Insulin-resistant Non-obese Humans: Metabolic Benefits and Relationship to Adipose Cell Size

Overview

Journal Nutr Metab Cardiovasc Dis

Publisher Elsevier

Specialties Cardiology & Vascular Diseases
Endocrinology
Nutritional Sciences

Date 2018 Dec 1

PMID 30497926

Citations 9

Authors

T McLaughlin

F Abbasi

C Lamendola

G Yee

S Carter

S W Cushman

Affiliations

Soon will be listed here.

Abstract

Background And Aims: Overweight and obesity increase risk for diabetes and cardiovascular disease, largely through development of insulin resistance. Benefits of dietary weight loss are documented for obese individuals with insulin resistance. Similar benefits have not been shown in overweight individuals. We sought to quantify whether dietary weight loss improves metabolic risk profile in overweight insulin-resistant individuals, and evaluated potential mediators between weight loss and metabolic response.

Methods And Results: Healthy volunteers with BMI 25-29.9 kg/m underwent detailed metabolic phenotyping including insulin-mediated-glucose disposal, fasting/daylong glucose, insulin, triglycerides, FFA, and cholesterol. Subcutaneous fat biopsies were performed for measurement of adipose cell size. After 14 weeks of hypocaloric diet and 2 weeks of weight maintenance, cardiometabolic measures and biopsies were repeated. Changes in weight, % body fat, waist circumference, adipose cell size and FFA were evaluated as predictors of change in insulin resistance. Weight loss (4.3 kg) yielded significant improvements in insulin resistance and all cardiovascular risk markers except glucose, HDL-C, and LDL-C. Improvement in insulin sensitivity was greater among those with <2 vs >2 cardiovascular risk factors at baseline. Decrease in adipose cell size and waist circumference, but not weight or body fat, independently predicted improvement in insulin resistance.

Conclusions: Weight loss yields metabolic health benefits in insulin-resistant overweight adults, even in the absence of classic cardiovascular risk factors. Weight loss-related improvement in insulin sensitivity may be mediated through changes in adipose cell size and/or central distribution of body fat. The insulin-resistant subgroup of overweight individuals should be identified and targeted for dietary weight loss.

Clinical Trials Identifier: NCT00186459.

Citing Articles

Feasibility of Different Exercise Modalities for Community-Dwelling Residents With Physical Inactivity: A Randomized Controlled Trial.

Chang Y, Shun S, Chen M, Chang Y J Nurs Res. 2023; 31(6):e301.

PMID: 37883059 PMC: 11812666. DOI: 10.1097/jnr.0000000000000578.

The Effects of Ketogenic Diet on Insulin Sensitivity and Weight Loss, Which Came First: The Chicken or the Egg?.

Paoli A, Bianco A, Moro T, Mota J, Coelho-Ravagnani C Nutrients. 2023; 15(14).

PMID: 37513538 PMC: 10385501. DOI: 10.3390/nu15143120.

Clinical Impact of Semaglutide, a Glucagon-Like Peptide-1 Receptor Agonist, on Obesity Management: A Review.

Alorfi N, Algarni A Clin Pharmacol. 2022; 14:61-67.

PMID: 35958046 PMC: 9357557. DOI: 10.2147/CPAA.S374741.

Assessing Obesity-Related Adipose Tissue Disease (OrAD) to Improve Precision Medicine for Patients Living With Obesity.

Pincu Y, Yoel U, Haim Y, Makarenkov N, Maixner N, Shaco-Levy R Front Endocrinol (Lausanne). 2022; 13:860799.

PMID: 35574032 PMC: 9098964. DOI: 10.3389/fendo.2022.860799.

Fat Cell Size: Measurement Methods, Pathophysiological Origins, and Relationships With Metabolic Dysregulations.

Ye R, Richard G, Gevry N, Tchernof A, Carpentier A Endocr Rev. 2021; 43(1):35-60.

PMID: 34100954 PMC: 8755996. DOI: 10.1210/endrev/bnab018.

References

Salans L, DOUGHERTY J . The effect of insulin upon glucose metabolism by adipose cells of different size. Influence of cell lipid and protein content, age, and nutritional state. J Clin Invest. 1971; 50(7):1399-410. PMC: 292078. DOI: 10.1172/JCI106623. View

McLaughlin T, Allison G, Abbasi F, Lamendola C, Reaven G . Prevalence of insulin resistance and associated cardiovascular disease risk factors among normal weight, overweight, and obese individuals. Metabolism. 2004; 53(4):495-9. DOI: 10.1016/j.metabol.2003.10.032. View

Kloting N, Bluher M . Adipocyte dysfunction, inflammation and metabolic syndrome. Rev Endocr Metab Disord. 2014; 15(4):277-87. DOI: 10.1007/s11154-014-9301-0. View

Cinti S, Mitchell G, Barbatelli G, Murano I, Ceresi E, Faloia E . Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res. 2005; 46(11):2347-55. DOI: 10.1194/jlr.M500294-JLR200. View

Deurenberg P, Weststrate J, Seidell J . Body mass index as a measure of body fatness: age- and sex-specific prediction formulas. Br J Nutr. 1991; 65(2):105-14. DOI: 10.1079/bjn19910073. View

Facchini F, Hua N, Abbasi F, Reaven G . Insulin resistance as a predictor of age-related diseases. J Clin Endocrinol Metab. 2001; 86(8):3574-8. DOI: 10.1210/jcem.86.8.7763. View

McLaughlin T, Carter S, Lamendola C, Abbasi F, Yee G, Schaaf P . Effects of moderate variations in macronutrient composition on weight loss and reduction in cardiovascular disease risk in obese, insulin-resistant adults. Am J Clin Nutr. 2006; 84(4):813-21. DOI: 10.1093/ajcn/84.4.813. View

Harrington M, Gibson S, Cottrell R . A review and meta-analysis of the effect of weight loss on all-cause mortality risk. Nutr Res Rev. 2009; 22(1):93-108. DOI: 10.1017/S0954422409990035. View

Andersson D, Hogling D, Thorell A, Toft E, Qvisth V, Naslund E . Changes in subcutaneous fat cell volume and insulin sensitivity after weight loss. Diabetes Care. 2014; 37(7):1831-6. DOI: 10.2337/dc13-2395. View

10.

Pischon T, Boeing H, Hoffmann K, Bergmann M, Schulze M, Overvad K . General and abdominal adiposity and risk of death in Europe. N Engl J Med. 2008; 359(20):2105-20. DOI: 10.1056/NEJMoa0801891. View

11.

Eriksson-Hogling D, Andersson D, Backdahl J, Hoffstedt J, Rossner S, Thorell A . Adipose tissue morphology predicts improved insulin sensitivity following moderate or pronounced weight loss. Int J Obes (Lond). 2015; 39(6):893-8. DOI: 10.1038/ijo.2015.18. View

12.

McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, Reaven G . Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med. 2003; 139(10):802-9. DOI: 10.7326/0003-4819-139-10-200311180-00007. View

13.

Rexrode K, Carey V, Hennekens C, Walters E, Colditz G, Stampfer M . Abdominal adiposity and coronary heart disease in women. JAMA. 1998; 280(21):1843-8. DOI: 10.1001/jama.280.21.1843. View

14.

McLaughlin T, Deng A, Yee G, Lamendola C, Reaven G, Tsao P . Inflammation in subcutaneous adipose tissue: relationship to adipose cell size. Diabetologia. 2009; 53(2):369-77. PMC: 6290757. DOI: 10.1007/s00125-009-1496-3. View

15.

McGee D . Body mass index and mortality: a meta-analysis based on person-level data from twenty-six observational studies. Ann Epidemiol. 2005; 15(2):87-97. DOI: 10.1016/j.annepidem.2004.05.012. View

16.

Wentworth J, Naselli G, Brown W, Doyle L, Phipson B, Smyth G . Pro-inflammatory CD11c+CD206+ adipose tissue macrophages are associated with insulin resistance in human obesity. Diabetes. 2010; 59(7):1648-56. PMC: 2889764. DOI: 10.2337/db09-0287. View

17.

Ingram D, Mussolino M . Weight loss from maximum body weight and mortality: the Third National Health and Nutrition Examination Survey Linked Mortality File. Int J Obes (Lond). 2010; 34(6):1044-50. DOI: 10.1038/ijo.2010.41. View

18.

Flegal K, Kit B, Orpana H, Graubard B . Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA. 2013; 309(1):71-82. PMC: 4855514. DOI: 10.1001/jama.2012.113905. View

19.

Abbasi F, Brown Jr B, Lamendola C, McLaughlin T, Reaven G . Relationship between obesity, insulin resistance, and coronary heart disease risk. J Am Coll Cardiol. 2002; 40(5):937-43. DOI: 10.1016/s0735-1097(02)02051-x. View

20.

Carantoni M, Abbasi F, Reaven G . Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers. Diabetes Care. 2000; 23(2):171-5. DOI: 10.2337/diacare.23.2.171. View